Autism Tech Startups Aim for FDA Approval, Driving Efficiency, Market Growth

More startups are seeking Food and Drug Administration (FDA) clearance for autism spectrum disorders interventions beyond behavior therapies. While widely varied in type and approach, these companies seek to bring the scientific rigor and scrutiny that is more of a type with medical devices. The FDA clearance process provides something tantamount to a permission slip […]

AMFM Healthcare, Cognoa Name CEOs; CleanSlate Centers Announces New CMO

CleanSlate finds CMO Dr. Claudie Jimenez has been promoted to chief medical officer at outpatient medication-assisted treatment (MAT) provider CleanSlate Centers. Jimenez will now oversee CleanSlate’s medical initiatives, including all behavioral health programs. She is tasked with leading the integration of behavioral health counselors and medical providers to drive holistic treatment. CleanSlate was founded in […]

FDA Green Lights Cognoa’s Autism Diagnostic Device

As the health care system currently operates, it can take months or even years for children on the autism spectrum to get a diagnosis and begin applied behavioral analysis (ABA) therapy. Oftentimes, pediatricians are the first clinicians to see those children; however, few feel comfortable making the diagnosis themselves, instead referring children to autism specialists, […]

How Cognoa Aims to Revolutionize the Autism Diagnosis Process

Applied behavioral analysis (ABA) is widely considered the gold standard for autism treatment, but accessing ABA is easier said than done given the huge number of children on the spectrum.  In fact, families are often forced onto treatment waitlists due to the nationwide shortage of ABA clinicians. And that’s if they can get an autism […]